Junjie Zhou
State Key Laboratory Of New Targets Discovery And Drug Development For Major Diseases
Ganzhou, China
Ganzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Antioxidant malic-acid-derived lipid nanoparticles delivering secretory uricase circRNA for hyperuricemia and complication management in mice.
Journal: Nature communications
Published: December 02, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD.
Journal: Gut
Published: July 02, 2025
Species differences of fatty liver diseases: comparisons between human and feline.
Journal: American journal of physiology. Endocrinology and metabolism
Published: December 05, 2024
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression.
Journal: Science translational medicine
Published: February 14, 2024
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis.
Journal: The Journal of clinical investigation
Published: June 20, 2023
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase.
Journal: The Journal of clinical investigation
Published: October 10, 2022
SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Journal: PeerJ
Published: May 13, 2022
Isoperistaltic side-to-side anastomosis for the surgical treatment of Crohn disease.
Journal: Annals of surgical treatment and research
Published: April 04, 2022
CsAAP7.2 is involved in the uptake of amino acids from soil and the long-distance transport of theanine in tea plants (Camellia sinensis L.).
Journal: Tree physiology
Published: December 12, 2021
Last Updated: 09/26/2026